Janux Therapeutics, Inc.
JANX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001817713
No open-market purchases or sales by Janux Therapeutics, Inc. insiders were filed in the last 90 days; 197 institutions reported holding it in 13F filings for Q2 2026, worth $933.4M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Janux Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- +5 vs. Q2 2022
- Shares held
- 29.6M
- +647.2K (+2.2%) vs. Q2 2022
- Total value
- $400.3M
- +$47.3M (+13.4%) vs. Q2 2022
- New holders
- 5
- 17 more added
- Sold out
- 0
- 13 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 197 | $933.4M |
| Q1 2026 | 190 | $827.8M |
| Q4 2025 | 176 | $860.0M |
| Q3 2025 | 174 | $1.59B |
| Q2 2025 | 174 | $1.51B |
| Q1 2025 | 181 | $1.81B |
| Q4 2024 | 216 | $3.43B |
| Q3 2024 | 160 | $2.07B |
| Q2 2024 | 155 | $1.87B |
| Q1 2024 | 121 | $1.59B |
| Q4 2023 | 64 | $359.5M |
| Q3 2023 | 57 | $354.0M |
| Q2 2023 | 54 | $362.1M |
| Q1 2023 | 48 | $369.5M |
| Q4 2022 | 50 | $381.3M |
| Q3 2022 | 49 | $400.3M |
| Q2 2022 | 44 | $353.0M |
| Q1 2022 | 47 | $407.1M |
| Q4 2021 | 46 | $541.6M |
| Q3 2021 | 45 | $571.2M |
| Q2 2021 | 30 | $614.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Janux Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 45 | $1.00K | 0.00% | −29,595−99.8% | Reduced |
| Credit Suisse AG | 94 | $1.00K | 0.00% | +77+452.9% | Added |
| Capital Advisors, Ltd. LLC | 90 | $1.00K | 0.00% | +90 | New |
| Daiwa Securities Group Inc. | 121 | $2.00K | 0.00% | 00.0% | Unchanged |
| Crewe Advisors LLC | 115 | $2.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 234 | $3.00K | 0.00% | +137+141.2% | Added |
| China Universal Asset Management Co., Ltd. | 390 | $5.00K | 0.00% | +390 | New |
| Barclays PLC | 728 | $10.0K | 0.00% | −132−15.3% | Reduced |
| Citigroup Inc | 985 | $13.0K | 0.00% | −1,166−54.2% | Reduced |
| Ameritas Investment Partners, Inc. | 1,014 | $13.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,155 | $16.0K | 0.00% | −809−41.2% | Reduced |
| Metropolitan Life Insurance Co | 1,382 | $18.7K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,742 | $24.0K | 0.00% | +302+21.0% | Added |
| Amalgamated Bank | 2,182 | $30.0K | 0.00% | 00.0% | Unchanged |
| California State Teachers Retirement System | 6,774 | $92.0K | 0.00% | −564−7.7% | Reduced |
| BNP Paribas Arbitrage, SA | 7,638 | $103.4K | 0.00% | +7,638 | New |
| Deutsche Bank AG | 8,099 | $110.0K | 0.00% | −1,143−12.4% | Reduced |
| American International Group, Inc. | 8,147 | $110.0K | 0.00% | +115+1.4% | Added |
| MetLife Investment Management | 10,614 | $143.7K | 0.00% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 12,182 | $165.0K | 0.00% | +12,182 | New |
| New York State Common Retirement Fund | 13,259 | $180.0K | 0.00% | +5,246+65.5% | Added |
| Chicago Partners Investment Group LLC | 10,621 | $181.0K | 0.01% | +10,621 | New |
| Goldman Sachs Group Inc | 14,047 | $190.0K | 0.00% | −1,817−11.5% | Reduced |
| Bank of America Corp | 15,157 | $206.0K | 0.00% | −10,361−40.6% | Reduced |
| Rhumbline Advisers | 25,580 | $346.0K | 0.00% | +1,678+7.0% | Added |
| Parkwood LLC | 33,352 | $452.0K | 0.10% | −398−1.2% | Reduced |
| Charles Schwab Investment Management Inc | 46,563 | $631.0K | 0.00% | +4,053+9.5% | Added |
| DekaBank Deutsche Girozentrale | 49,500 | $669.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 50,093 | $679.0K | 0.00% | +7,707+18.2% | Added |
| Nuveen Asset Management, LLC | 72,877 | $987.0K | 0.00% | −1,996−2.7% | Reduced |
| JPMorgan Chase & Co | 105,053 | $1.42M | 0.00% | +1,575+1.5% | Added |
| Cerity Partners LLC | 105,933 | $1.43M | 0.02% | −45,000−29.8% | Reduced |
| Northern Trust Corp | 136,364 | $1.85M | 0.00% | +3,207+2.4% | Added |
| Morgan Stanley | 141,480 | $1.92M | 0.00% | +113,747+410.2% | Added |
| State Street Corp | 264,207 | $3.58M | 0.00% | +185+0.1% | Added |
| Geode Capital Management, LLC | 334,521 | $4.53M | 0.00% | +50,901+17.9% | Added |
| Samsara BioCapital, LLC | 360,414 | $4.88M | 1.14% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 400,000 | $5.42M | 0.01% | 00.0% | Unchanged |
| Woodline Partners LP | 400,181 | $5.42M | 0.08% | +113,798+39.7% | Added |
| 5AM Venture Management, LLC | 446,266 | $6.04M | 1.16% | 00.0% | Unchanged |
| Vanguard Group Inc | 760,474 | $10.3M | 0.00% | +110,834+17.1% | Added |
| BlackRock Inc. | 1,250,348 | $16.9M | 0.00% | +41,994+3.5% | Added |
| EcoR1 Capital, LLC | 1,421,319 | $19.2M | 0.57% | 00.0% | Unchanged |
| BVF Inc | 1,470,334 | $19.9M | 0.82% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,853,216 | $25.1M | 0.03% | −2160.0% | Reduced |
| Janus Henderson Group PLC | 1,960,044 | $26.5M | 0.02% | −167,753−7.9% | Reduced |
| OrbiMed Advisors LLC | 2,836,386 | $38.4M | 0.76% | 00.0% | Unchanged |
| FMR LLC | 6,247,392 | $84.6M | 0.01% | +421,688+7.2% | Added |
| Ra Capital Management, L.P. | 8,670,644 | $117.4M | 2.50% | 00.0% | Unchanged |